By:
On:
In: Alzheimers, Arthritis, Bones & Joints, Mental Health, Neurological, Public Health, Seniors

THURSDAY, Sept. 9, 2021 (HealthDay News) — It’s more than just an annoyance: Long-term exposure to traffic and train noise may increase the risk of dementia and Alzheimer’s disease, Danish researchers report. The study authors said that more than 1,200 of Denmark’s nearly 8,500 cases of dementia in 2017 mayContinue Reading

By:
On:
In: Alzheimers, Diabetes, Mental Health, Neurological, Seniors

THURSDAY, Aug. 12, 2021 (HealthDay News) — Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests. Researchers in South Korea found that among older people who’d been having memory issues, those using diabetes drugs called DDP-4 inhibitorsContinue Reading

By:
On:
In: Alzheimers, Health & Technology, Heart / Cardiovascular, Public Health, Seniors

FRIDAY, July 30, 2021 (HealthDay News) — Death rates from Alzheimer’s disease are particularly high in the rural United States, a preliminary study finds, highlighting a need for health care resources in traditionally under-served areas. Researchers discovered that over the past two decades, rural areas in the Southeast have seenContinue Reading

By:
On:
In: Alzheimers, Public Health, Vitamins / Drugs

WEDNESDAY, July 28, 2021 (HealthDay News) — An outside advisor to the U.S. Food and Drug Administration’s review of the controversial Alzheimer’s drug Aduhelm is now speaking out, arguing that the approval was based on dodgy science and involved questionable collaboration between regulators and the drug’s maker. “I’m not surprisedContinue Reading

By:
On:
In: Alzheimers, Health & Technology, Mental Health, Neurological

TUESDAY, July 27, 2021 (HealthDay News) — While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound. According to a pair of small new studies, exposing Alzheimer’s patients to an hour a day of carefullyContinue Reading

By:
On:
In: Alzheimers, General Health, Mental Health, Neurological, Public Health, Vitamins / Drugs

FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

By:
On:
In: Alzheimers, Health & Technology, Healthy Living, Medical Disorders, Mental Health, Neurological, Vitamins / Drugs

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading